PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Intensive Care Unit, People\'s Hospital of Ningxia Hui Autonomous Region, Yinchuan 750001, Ningxia Hui Autonomous Region, China.\', \'General Hospital of Ningxia Medical University, Yinchuan 750004, Ningxia Hui Autonomous Region, China.\', \'The Fourth People\'s Hospital of Ningxia Hui Autonomous Region, Yinchuan 750001, Ningxia Hui Autonomous Region, China.\', \'The Third People\'s Hospital of Ningxia Hui Autonomous Region, Yinchuan 750001, Ningxia Hui Autonomous Region, China. Gao Xiaofang is the member of COVID-19 treatment expert group to the Fourth People\'s Hospital of Ningxia Hui Autonomous Region, Gao Xiaofang and Wei Jianhua have the same contribution to this paper. Corresponding author: Cao Xiangyuan, Email: c_xyuan@sina.com.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.3760/cma.j.cn121430-20201019-00679
?:hasPublicationType
?:journal
  • Zhonghua wei zhong bing ji jiu yi xue
is ?:pmid of
?:pmid
?:pmid
  • 33541491
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.15
?:rankingScore_hIndex
  • 5
is ?:relation_isRelatedTo_publication of
?:title
  • [Clinical efficacy and safety of different antiviral regimens in patients with coronavirus disease 2019].
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all